Simon T. Barry
- Molecular Biology top 2%
- Biomedical Engineering top 2%
- Biomaterials top 0.5%
- Oncology top 2%
- Cell Biology top 1%
- Co-authors
- David R. CritchleyJennifer I. HareMarianne AshfordSanyogitta PuriTwan LammersGert StormDavid C. BlakeyUma Prabhakar
- Topics
- PI3K/AKT/mTOR signaling in cancer (19 papers)Cell Adhesion Molecules Research (14 papers)Angiogenesis and VEGF in Cancer (12 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Simon T. Barry
118 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Molecular Biology 2.8k
- Biomedical Engineering 1.5k
- Biomaterials 1.4k
- Oncology 1.4k
- Cell Biology 936
Countries citing papers authored by Simon T. Barry
This map shows the geographic impact of Simon T. Barry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon T. Barry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon T. Barry more than expected).
Fields of papers citing papers by Simon T. Barry
This network shows the impact of papers produced by Simon T. Barry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon T. Barry. The network helps show where Simon T. Barry may publish in the future.
Co-authorship network of co-authors of Simon T. Barry
This figure shows the co-authorship network connecting the top 25 collaborators of Simon T. Barry. A scholar is included among the top collaborators of Simon T. Barry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon T. Barry. Simon T. Barry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 6 | |
| 3 | 3 | |
| 4 | 12 | |
| 5 | 18 | |
| 6 | 38 | |
| 7 | 6 | |
| 8 | 14 | |
| 9 | 1 | |
| 10 | 2 | |
| 11 | 21 | |
| 12 | 16 | |
| 13 | 18 | |
| 14 | 29 | |
| 15 | 24 | |
| 16 | 58 | |
| 17 | 93 | |
| 18 | 111 | |
| 19 | 47 | |
| 20 | 72 |
About Simon T. Barry
Simon T. Barry is a scholar working on Immunology and Allergy, Cancer Research and Oncology, having authored 123 papers that have together received 6.1k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (19 papers), Cell Adhesion Molecules Research (14 papers) and Angiogenesis and VEGF in Cancer (12 papers). The work is most often cited by research in Immunology and Allergy (800 citations), Biomaterials (1.4k citations) and Cell Biology (936 citations). Simon T. Barry has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include David R. Critchley, Jennifer I. Hare, Marianne Ashford, Sanyogitta Puri, Twan Lammers, Gert Storm, David C. Blakey, Uma Prabhakar, Omid C. Farokhzad and William C. Zamboni. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.